Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey.
Publication/Presentation Date
2-1-2022
Abstract
BACKGROUND: Cardiac implantable electronic device (CIED) implantation rates as well as the clinical and procedural characteristics and outcomes in patients with known active coronavirus disease 2019 (COVID-19) are unknown.
OBJECTIVE: The purpose of this study was to gather information regarding CIED procedures during active COVID-19, performed with personal protective equipment, based on an international survey.
METHODS: Fifty-three centers from 13 countries across 4 continents provided information on 166 patients with known active COVID-19 who underwent a CIED procedure.
RESULTS: The CIED procedure rate in 133,655 hospitalized COVID-19 patients ranged from 0 to 16.2 per 1000 patients (P < .001). Most devices were implanted due to high-degree/complete atrioventricular block (112 [67.5%]) or sick sinus syndrome (31 [18.7%]). Of the 166 patients in the study survey, the 30-day complication rate was 13.9% and the 180-day mortality rate was 9.6%. One patient had a fatal outcome as a direct result of the procedure. Differences in patient and procedural characteristics and outcomes were found between Europe and North America. An older population (76.6 vs 66 years; P < .001) with a nonsignificant higher complication rate (16.5% vs 7.7%; P = .2) was observed in Europe vs North America, whereas higher rates of critically ill patients (33.3% vs 3.3%; P < .001) and mortality (26.9% vs 5%; P = .002) were observed in North America vs Europe.
CONCLUSION: CIED procedure rates during known active COVID-19 disease varied greatly, from 0 to 16.2 per 1000 hospitalized COVID-19 patients worldwide. Patients with active COVID-19 infection who underwent CIED implantation had high complication and mortality rates. Operators should take these risks into consideration before proceeding with CIED implantation in active COVID-19 patients.
Volume
19
Issue
2
First Page
206
Last Page
216
ISSN
1556-3871
Published In/Presented At
Tovia-Brodie, O., Rav Acha, M., Belhassen, B., Gasperetti, A., Schiavone, M., Forleo, G. B., Guevara-Valdivia, M. E., Ruiz, D. V., Lellouche, N., Hamon, D., Castagno, D., Bellettini, M., De Ferrari, G. M., Laredo, M., Carvès, J. B., Ignatiuk, B., Pasquetto, G., De Filippo, P., Malanchini, G., Pavri, B. B., … Michowitz, Y. (2022). Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey. Heart rhythm, 19(2), 206–216. https://doi.org/10.1016/j.hrthm.2021.10.020
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
34710561
Department(s)
Administration and Leadership
Document Type
Article